Danish Carvedilol Study in Portal Hypertension

PHASE3CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 30, 2003

Primary Completion Date

August 31, 2009

Study Completion Date

August 31, 2009

Conditions
CirrhosisPortal Hypertension
Interventions
DRUG

carvedilol

6.25 mg of carvedilol for 12 weeks, to achieve a satisfactory pulse reduction the doses are doubled weekly up to a maximum of 25 mg carvedilol daily.

DRUG

propranolol

80 mg of propranolol for 12 weeks, to achieve a satisfactory pulse reduction the doses are doubles weekly up to a maximum of 360 mg propranolol daily

Trial Locations (1)

2650

Hvidovre Hospital, Hvidovre

All Listed Sponsors
lead

Hvidovre University Hospital

OTHER

NCT00493480 - Danish Carvedilol Study in Portal Hypertension | Biotech Hunter | Biotech Hunter